Mina Stemm

Extensive range of experience spanning biopharmaceuticals (cell/gene therapies), tissue-based biologics; implantable medical devices, capital equipment, and diagnostics, with expertise in Business Development, Strategy, and Market Access/Reimbursement of Part A/B (physician administered inpatient/outpatient) Drugs and Devices. 20+ years of experience throughout the product life cycle in oncology, rare disease, procedure-based therapies, and chronic disease, most recently diabetic kidney disease and diabetes. Scientifically minded, creative out-of-box thinker, resourceful, collaborative across disciplines, and focused on exceeding stakeholder expectations with integrity.